WO2024251855 - HETEROARYL DERIVATIVES AS DDRS INHIBITORS
National phase entry is expected:
Publication Number
WO/2024/251855
Publication Date
12.12.2024
International Application No.
PCT/EP2024/065550
International Filing Date
06.06.2024
Title **
[English]
HETEROARYL DERIVATIVES AS DDRS INHIBITORS
[French]
DÉRIVÉS D'HÉTÉROARYLE EN TANT QU'INHIBITEURS DE DDRS
Applicants **
CHIESI FARMACEUTICI S.P.A.
Via Palermo 26/A
43122 Parma, IT
Inventors
CARZANIGA, Laura
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
RANCATI, Fabio
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
SPENCER, Jonathan Andrew
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
WHITTAKER, Benjamin Paul
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
HAMASOVA, Zuzana
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
RIZZI, Andrea
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
MAZZUCATO, Roberta
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
LEVANTO, Stefano
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
CHAPMAN, Robert Stuart Laurie
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
FUMAGALLI, Gabriele
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
IOTTI, Nicolò
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
GIULIANI, Marta
c/o Chiesi Farmaceutici S.p.a.
Via Palermo 26/A
43122 Parma, IT
STIMPSON, Dean Alfie
c/o Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma, IT
Priority Data
23177905.9
07.06.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 5630 | |
| EPO | Filing, Examination | 81294 | |
| Japan | Filing | 593 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 83235 |
Total: 171327 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to compounds of formula (I) inhibiting Discoidin Domain Receptors (DDR inhibitors), methods of preparing such compounds, intermediate compounds useful in such preparations, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful for instance in the treatment of many disorders associated with DDR mechanisms.[French]
La présente invention concerne des composés de formule (I) inhibant les récepteurs du domaine discoïdine (inhibiteurs de DDR), des procédés de préparation de tels composés, des composés intermédiaires utiles dans de telles préparations, des compositions pharmaceutiques les contenant et leur utilisation thérapeutique. Les composés de l'invention peuvent être utiles, par exemple, dans le traitement de nombreux troubles associés aux mécanismes DDR.